Health Care & Life Sciences » Pharmaceuticals | Kobayashi Pharmaceutical Co. Ltd.

Kobayashi Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
47,368
55,451
62,949
63,673
73,290
82,756
Total Accounts Receivable
30,760
34,428
35,969
47,045
49,998
53,255
Inventories
11,197
10,531
12,484
12,805
13,289
13,643
Other Current Assets
5,028
5,204
4,588
5,123
5,768
5,401
Total Current Assets
94,353
105,614
115,990
128,646
142,346
155,058
Net Property, Plant & Equipment
13,730
14,945
16,023
17,833
18,247
19,024
Total Investments and Advances
40,958
41,817
44,472
43,234
49,778
48,872
Long-Term Note Receivable
281
598
668
50
21
37
Intangible Assets
5,092
5,426
5,582
7,223
4,798
4,823
Other Assets
2,368
1,681
3,278
3,865
3,099
2,577
Total Assets
157,106
170,919
186,331
201,234
218,831
230,989
ST Debt & Current Portion LT Debt
266
164
122
248
249
Accounts Payable
11,577
11,368
13,521
16,018
17,500
Income Tax Payable
4,091
3,639
3,270
3,601
4,800
Other Current Liabilities
18,543
19,045
18,977
27,108
31,725
Total Current Liabilities
34,477
34,216
35,890
46,975
54,274
Long-Term Debt
626
1,060
975
1,047
1,003
Provision for Risks & Charges
4,903
5,976
5,613
4,450
2,923
Deferred Taxes
324
329
2,365
3,458
4,685
Other Liabilities
2,228
1,547
1,559
1,601
1,592
Total Liabilities
42,234
43,966
46,720
57,914
65,016
Common Equity (Total)
114,872
126,953
139,589
143,320
153,811
Total Shareholders' Equity
114,872
126,953
139,589
143,320
153,811
Total Equity
114,872
126,953
139,611
143,320
153,811
Liabilities & Shareholders' Equity
157,106
170,919
186,331
201,234
218,827
Accumulated Minority Interest
-
-
22
-
-

About Kobayashi Pharmaceutical Co.

View Profile
Address
KDX Kobayashi Doshomachi Building
Osaka Osaka 541
Japan
Employees -
Website http://www.kobayashi.co.jp
Updated 07/08/2019
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals, non-pharmaceuticals, deodorizers, and sanitary products. It operates through the following segments: Domestic Consumer Products Business, Overseas Consumer Products Business, Direct Marketing Business, and Other. The Domestic Consumer Products Business segment manufactures and sells body warmers, healthcare, household, and skincare products.